Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alliance Pharma PLC (GB:APH)
LSE:APH
Alliance Pharma (APH) Share Price & Analysis
35 Followers
APH Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range24.55p - 52.80p
Previous Close37.6p
Volume455.67K
Average Volume (3M)2.67M
Market Cap
£203.25M
Enterprise Value309.11M
Total Cash (Recent Filing)£31.71M
Total Debt (Recent Filing)£137.58M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Sep 24, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 22, 2023Dividend Yield4.72%
Share Statistics
EPS (TTM)-0.06
Shares Outstanding540,150,223
10 Day Avg. Volume921,555
30 Day Avg. Volume2,669,917
Standard Deviation0.08
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-1.71
Price to Sales (P/S)275.53
Price to Cash Flow (P/CF)7.30
P/FCF Ratio6.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.50pPrice Target Upside106.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Alliance Pharma News
PremiumCompany Announcements
Alliance Pharma Announces AGM and Growth Strategy
PremiumCompany Announcements
Alliance Pharma Reports Total Voting Rights
PremiumCompany Announcements
Alliance Pharma Grants CEO Performance-Based Options
PremiumCompany Announcements
Alliance Pharma Share Ownership Shift NotedPremiumCompany Announcements
Alliance Pharma Shareholding Shift Noted
PremiumCompany Announcements
Alliance Pharma Stakeholder Voting Rights Shift
PremiumCompany Announcements
Alliance Pharma Reports Strong 2023 Financials
PremiumCompany Announcements
Alliance Pharma Witnesses Major Share Ownership ShiftOptions Prices
Currently, No data available
---
Ownership Overview
11.23% Insiders
4.83% Mutual Funds
0.06% Other Institutional Investors
83.88% Public Companies and
Individual Investors
APH FAQ
What was Alliance Pharma PLC’s price range in the past 12 months?
Alliance Pharma PLC lowest share price was 24.55p and its highest was 52.80p in the past 12 months.
What is Alliance Pharma PLC’s market cap?
Currently, no data Available
When is Alliance Pharma PLC’s upcoming earnings report date?
Alliance Pharma PLC’s upcoming earnings report date is Sep 24, 2024 which is in 80 days.
How were Alliance Pharma PLC’s earnings last quarter?
Alliance Pharma PLC released its earnings results on Jun 19, 2024. The company reported -0.071p earnings per share for the quarter, missing the consensus estimate of 0.029p by -0.1p.
Is Alliance Pharma PLC overvalued?
According to Wall Street analysts Alliance Pharma PLC’s price is currently Undervalued.
Does Alliance Pharma PLC pay dividends?
Alliance Pharma PLC pays a Annually dividend of 1.18p which represents an annual dividend yield of 4.72%. See more information on Alliance Pharma PLC dividends here
What is Alliance Pharma PLC’s EPS estimate?
Alliance Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alliance Pharma PLC have?
Alliance Pharma PLC has 540,565,550 shares outstanding.
What happened to Alliance Pharma PLC’s price movement after its last earnings report?
Alliance Pharma PLC reported an EPS of -0.071p in its last earnings report, missing expectations of 0.029p. Following the earnings report the stock price went up 12.676%.
Which hedge fund is a major shareholder of Alliance Pharma PLC?
Currently, no hedge funds are holding shares in GB:APH
---
Alliance Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
77.50p (106.12% Upside)
77.50p (106.12% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.65%
12-Months-Change
Fundamentals
Return on Equity
-13.11%
Trailing 12-Months
Asset Growth
-22.79%
Trailing 12-Months
Company Description
Alliance Pharma PLC
Alliance Pharma PLC is a player in the healthcare market. The company's business includes acquisition, marketing, and distribution of pharmaceutical products. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol.
---
APH Stock 12 Month Forecast
Average Price Target
77.50p
▲(106.12% Upside)
Technical Analysis
Advanced Medical Solutions
―
Futura Medical
―
Hikma Pharmaceuticals
―
Scancell Holdings
―
Best Analysts Covering APH
1 Year
1 Year Success Rate
1/13 ratings generated profit
1 Year Average Return
-28.39%
assigned a buy rating 5 months ago
Copying Charles Weston's trades and holding each position for 1 Year would result in 7.69% of your transactions generating a profit, with an average return of -28.39% per trade.
---